International Stem Cell ISCO
OTC ISCO
$0.21 -0.05 (-19.23%)
As of: Oct 21, 2026 · 10:19 AM EDT

International Stem Cell (ISCO) Other non-cash items (2012 - 2025)

Updated

Analysis

International Stem Cell (ISCO) Other non-cash items (2012 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 International Stem Cell 1.36 Mn -2.61 Mn 1.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 97,000.00
Sep 30, 2025 53,000.00
Jun 30, 2025 65,000.00
Mar 31, 2025 140,000.00
Dec 31, 2024 41,000.00
Sep 30, 2024 32,000.00
Jun 30, 2024 63,000.00
Mar 31, 2024 83,000.00
Dec 31, 2023 109,000.00
Sep 30, 2023 53,000.00
Jun 30, 2023 71,000.00
Mar 31, 2023 40,000.00
Dec 31, 2022 37,000.00
Sep 30, 2022 36,000.00
Jun 30, 2022 35,000.00
Mar 31, 2022 33,000.00
Dec 31, 2021 73,000.00
Sep 30, 2021 -402,000.00
Jun 30, 2021 -661,000.00
Mar 31, 2021 69,000.00
API Access

International Stem Cell Other non-cash items API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-cash-items&ticker=ISCO&period=max&api_key=YOUR_API_KEY